Search | Clinical Trials Finder

The live registry is temporarily unavailable. These stored records may be incomplete or out of date. Check the official record for current status and contact information.

ClinicalTrials.gov public records Last synced Oct 19, 2026, 12:16 PM EDT

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2305–2328 of 2,922 matching trials from the local directory fallback.

Filters: Condition: Disorder Clear all

Conditions: Cognitive Dysfunction, Memory Disorders in Old Age
Interventions: Active Theta Burst Stimulation, Sham Theta Burst Stimulation; Device
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 55 Years to 100 Years
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2026
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Behavioral Disorder, Endocrine System Disorder
Interventions: Focus Group, Health Education, Internet-Based Intervention, Interview, Questionnaire Administration; Other · Behavioral
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 21 Years to 65 Years
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2030
U.S. locations: 2
States / cities: Houston, Texas

Conditions: Brain and Central Nervous System Tumors, Chronic Myeloproliferative Disorders, Leukemia, Lymphoma, Lymphoproliferative Disorder, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms, Unspecified Adult Solid Tumor, Protocol Specific
Interventions: 3'-deoxy-3'-[18F]fluorothymidine; Device
Lead sponsor: Barbara Ann Karmanos Cancer Institute; Other
Eligibility: 18 Years to 120 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2027
U.S. locations: 1
States / cities: Detroit, Michigan

Conditions: Atypical Parkinsonism, PARKINSON DISEASE (Disorder)
Interventions: Autologous Bone Marrow Aspirate (BMA) and Bone Marrow Aspirate Concentrate (BMAC); Biological
Lead sponsor: Apeiron Research Center; Other
Eligibility: 40 Years to 85 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Boulder, Colorado

Conditions: Lipoprotein Disorder
Interventions: DII235, Saline; Drug
Lead sponsor: Novartis Pharmaceuticals; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 234 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 37
States / cities: Birmingham, Alabama • Huntsville, Alabama • Little Rock, Arkansas + 33 more

Conditions: Sacroiliac Disorder, Sacroiliac Joint Dysfunction, Sacroiliac Joint Pain, Sacroiliac; Fusion
Interventions: Use of iFuse TORQ; Device
Lead sponsor: SI-BONE, Inc.; Industry
Eligibility: 21 Years and older
Enrollment: 110 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 14
States / cities: Napa, California • Santa Monica, California • Shelbyville, Indiana + 11 more

Conditions: Substance Use Disorders
Interventions: Control-like parameter estimation, Modified Family Talk; Other
Lead sponsor: Brown University; Other
Eligibility: 12 Years and older
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Pawtucket, Rhode Island

Conditions: Hematopoietic and Lymphoid Cell Neoplasm, High Risk Acute Myeloid Leukemia, High Risk Myelodysplastic Syndrome, Lymphoproliferative Disorder, Myelodysplastic Syndrome, Myelodysplastic/Myeloproliferative Neoplasm, Recurrent Acute Lymphoblastic Leukemia, Recurrent Acute Myeloid Leukemia, Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Recurrent High Risk Myelodysplastic Syndrome, Recurrent Hodgkin Lymphoma, Recurrent Myelodysplastic Syndrome, Recurrent Non-Hodgkin Lymphoma, Recurrent Plasma Cell Myeloma
Interventions: Allogeneic Hematopoietic Stem Cell Transplantation, Busulfan, Cyclophosphamide, Fludarabine, Fludarabine Phosphate, Laboratory Biomarker Analysis, Mycophenolate Mofetil, Pharmacological Study, Tacrolimus, Thiotepa; Procedure · Drug · Other
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 12 Years to 75 Years
Enrollment: 204 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2028
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Autism Disorder, Intellectual Disability, Tuberous Sclerosis
Interventions: Not listed
Lead sponsor: Boston Children's Hospital; Other
Eligibility: 18 Months and older
Enrollment: 205 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2026
U.S. locations: 6
States / cities: Birmingham, Alabama • Los Angeles, California • Palo Alto, California + 3 more

Conditions: Autism Spectrum Disorder, Intellectual Disability, Phelan-McDermid Syndrome
Interventions: Not listed
Lead sponsor: Boston Children's Hospital; Other
Eligibility: 18 Months and older
Enrollment: 207 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2026
U.S. locations: 5
States / cities: Stanford, California • Chicago, Illinois • Bethesda, Maryland + 2 more

Conditions: Feeding Disorders, Gastroparesis, Vomiting
Interventions: Not listed
Lead sponsor: Boston Children's Hospital; Other
Eligibility: 30 Days to 18 Years
Enrollment: 100 participants
Timeline: 2020 – 2027
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Binge-Eating Disorder, Bulimia Nervosa, Eating Disorder, Obesity
Interventions: Negative Affect Task; Behavioral
Lead sponsor: University of California, San Diego; Other
Eligibility: 18 Years to 55 Years
Enrollment: 410 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2027
U.S. locations: 1
States / cities: San Diego, California

Conditions: Alcohol-Related Disorders, Drug Use Disorders, Illicit Drug Use
Interventions: Care Navigation; Behavioral
Lead sponsor: Kaiser Permanente; Other
Eligibility: 18 Years and older
Enrollment: 74 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Allogeneic Hematopoietic Cell Transplant, EBV+ Lymphoproliferative Disease With Acquired (Non-congenital) Immunodeficiency (EBV+ AID LPD), EBV+ Lymphoproliferative Disease With Primary Immunodeficiency (EBV+ PID LPD), EBV+ Post-transplant Lymphoproliferative Disease (EBV+ PTLD), EBV+ Posttransplant Lymphoproliferative Disease in Central Nervous System (EBV+ CNS PTLD), EBV+ Sarcomas, Epstein-Barr Virus (EBV)-Associated Diseases, Leiomyosarcoma, Lymphoproliferative Disorders, Solid Organ Transplant Complications, Stem Cell Transplant Complications
Interventions: Tabelecleucel; Biological
Lead sponsor: Pierre Fabre Medicament; Industry
Eligibility: Not listed
Enrollment: 190 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2028
U.S. locations: 23
States / cities: Los Angeles, California • Orange, California • Palo Alto, California + 18 more

Conditions: Immune System Diseases, Immunoproliferative Disorders, Lymphatic Diseases, Lymphoma, Lymphoma, B-Cell
Interventions: AP1903, Bendamustine, Cyclophosphamide, Fludarabine, iC9-CAR19 T cells; Drug · Biological
Lead sponsor: UNC Lineberger Comprehensive Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2040
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Bile Acid Synthesis Disorders
Interventions: Cholbam; Drug
Lead sponsor: Mirum Pharmaceuticals, Inc.; Industry
Eligibility: Not listed
Enrollment: 55 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2039
U.S. locations: 24
States / cities: Birmingham, Alabama • Palo Alto, California • San Francisco, California + 18 more

Conditions: Anxiety Disorder of Childhood or Adolescence, Generalized Anxiety Disorder (GAD), Obsessive Compulsive Disorder (OCD), Panic Attacks, Panic Disorder, Panic Disorder (With or Without Agoraphobia), Phobia, Specific, Separation Anxiety Disorder, Social Anxiety Disorder of Childhood
Interventions: Family Based, Internet-Based Cognitive Behavioral Therapy, Parent Coached Exposure Therapy; Behavioral
Lead sponsor: Baylor College of Medicine; Other
Eligibility: 7 Years to 17 Years
Enrollment: 174 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Healthy Adult Volunteer, Major Depressive Disorder (MDD)
Interventions: ATHF, Clinical assessments, Cold cognitive tasks, Four self-report measures to assess interpersonal functioning, Hot Cognitive Task, Magnetoencephalography imaging (MEG), Structural magnetic resonance imaging (sMRI), four self-report forms per the requirement of the NIH Common Data Elements project; Other · Behavioral
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 21 Years to 80 Years
Enrollment: 276 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2027
U.S. locations: 2
States / cities: Arlington, Texas • Dallas, Texas

Conditions: Obsessive-Compulsive Disorder
Interventions: Not listed
Lead sponsor: Baylor College of Medicine; Other
Eligibility: 18 Years to 64 Years
Enrollment: 8 participants
Timeline: 2021 – 2027
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Depression, Tobacco Use Disorder
Interventions: Behavioral Activation Therapy, Discussion, Health Education, Questionnaire Administration, Tobacco Cessation Counseling; Behavioral · Procedure · Other
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 26 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2027
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Opioid Use Disorder
Interventions: Naloxone Nasal Spray; Drug
Lead sponsor: University of Maryland, Baltimore; Other
Eligibility: 18 Years and older
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2030
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Alcohol Use Disorder
Interventions: Cognitive-Behavioral Treatment; Behavioral
Lead sponsor: University of South Florida; Other
Eligibility: 18 Years and older
Enrollment: 250 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: Tampa, Florida

Conditions: Eating Disorders, Sexual Minorities
Interventions: Promoting Resilience to Improve Disordered Eating; Behavioral
Lead sponsor: Auburn University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2027
U.S. locations: 2
States / cities: Auburn, Alabama • San Diego, California

Conditions: Schizoaffective Disorder, Schizophrenia
Interventions: Placebo Prebiotic, Prebiotic; Dietary Supplement
Lead sponsor: University of Maryland, Baltimore; Other
Eligibility: 18 Years to 60 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Catonsville, Maryland

Search by objective public record fields.

Network-targeted Theta-burst Stimulation for Episodic Memory Improvement in Mild Cognitive Impairment

Sleep and Physical Activity Intervention for Increasing Physical Activity in Overweight or Obese and Sedentary African Americans

3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer

Autologous Bone Marrow Aspirate (IV) and Bone Marrow Concentrate (Intranasal) for Parkinson's Disease and Parkinson-Plus Syndromes (SPARC-PD)

A Study of DII235 in Adults With Elevated Lipoprotein(a)

iFuse TORQ for the Treatment of Sacroiliac Joint Dysfunction

Substance Use Prevention for Youth With Parents in Recovery

Busulfan, Fludarabine Phosphate, and Post-Transplant Cyclophosphamide in Treating Patients With Blood Cancer Undergoing Donor Stem Cell Transplant

Autism Spectrum Disorder (ASD) and Intellectual Disability (ID) Determinants in Tuberous Sclerosis Complex (TSC)

Mapping the Genotype, Phenotype, and Natural History of Phelan-McDermid Syndrome

Use of Intrapyloric Botulinum Injections in Children

Effects of Negative Affect in Individuals With Binge Eating Episodes

Addressing Barriers to Care for Substance Use Disorder Pilot Study

A Study to Evaluate Tabelecleucel in Participants With Epstein Barr Virus (EBV) Associated Diseases

Anti-CD19 CAR-T Cells With Inducible Caspase 9 Safety Switch for B-cell Lymphoma

The REPLACE Registry for Cholbam® (Cholic Acid)

Comparative Effectiveness of Internet-based Versus Parent-Coached Cognitive-Behavioral Therapy For Children and Adolescents With Anxiety and OCD

Emotional Cognition: Establishing Constructs and Neural-Behavioral Mechanisms in Older Adults With Depression

Brain Recordings in Patients Undergoing Deep Brain Stimulation (DBS) for Severe Obsessive-Compulsive Disorder (OCD)

A Behavioral Activation Prenatal and Postpartum Intervention for Depressed Pregnant Smokers

Behavioral Pharmacological Examination of a Novel Buprenorphine Induction Method Among Individuals Who Use Fentanyl

Clinical Course of Alcohol Use Disorder Recovery

Targeting Minority Stressors to Improve Eating Disorder Symptoms in Sexual Minority Individuals With Eating Disorders

Prebiotic Treatment in People With Schizophrenia